Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 154.11 billion as of March 28, 2025. Its market cap has increased by 24.67% in one year.

Market Cap

154.11B

Enterprise Value

270.00B

Revenue

67.38B

Ranking

n/a

PE Ratio

n/a

Stock Price

804.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 154.11B, an increase of 4,745.26%. That is a compound annual growth rate of 14.19%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	154.11B	17.82%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,844.44B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings